Physician
Rheumatology
Dr. Stanley R. Pillemer, MD
|
|
Give Review
Doctor Stanley R. Pillemer, MD works in the field of Rheumatology. He has 1 awards "Fellow (FACR)". Stanley Pillemer is a published doctor as well. He has 88 publications published. The latest was: High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
Publications
- Microchimerism in salivary glands after blood- and marrow-derived stem cell transplantation.
- Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.
- Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept.
- Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging.
- Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
- Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
- Prominent adverse effects of thalidomide in primary Sjögren's syndrome.
- The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model.
- Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome.
- Fungal load and candidiasis in Sjögren's syndrome.
- Clinical evaluation of patients with temporomandibular joint implants.
- Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers.
- Elevated blood pressure is not related to saliva flow in patients with Sjögren's syndrome.
- Risk factors for positive minor salivary gland biopsy findings in Sjögren's syndrome and dry mouth patients.
- Xerostomia and the geriatric patient.
- Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis.
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
- Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis.
- Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
- Immunological consequences of thalidomide treatment in Sjögren's syndrome.
- Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians.
- Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period.
- High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
- Revisiting Sjögren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK.
- Alternate-day corticosteroid treatment, mood and plasma HVA in patients with systemic lupus erythematosus.
- Immunologic parameters of response in patients with rheumatoid arthritis treated with cyclosporin A.
- A cross-sectional and longitudinal comparison of the Rome criteria for active rheumatoid arthritis (equivalent to the American College of Rheumatology 1958 criteria) a...
- Sjögren's syndrome: a model for dental care in the 21st century.
- Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.
- Genealogy construction in a historically isolated population: application to genetic studies of rheumatoid arthritis in the Pima Indian.
- Sjögren's syndrome: a possible pathogenetic mechanism involving somatostatin.
- Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
- Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group.
- Experiments, evidence, and explanations.
- Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992.
- Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. MIRA Trial Group. Minocycline in RA.
- Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.
- Hip osteoarthritis prevalence estimates by three radiographic scoring systems.
- Enlarged acetabular labra in the Pima Indians.
- The neuroscience and endocrinology of fibromyalgia.
- A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis ...
- Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.
- Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis.
- Another look at minocycline.
- HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis.
- Low prevalences of chronic widespread pain and shoulder disorders among the Pima Indians.
- Anti-salivary antibodies in primary Sjögren's syndrome.
- Brachial plexus radiculopathy and computed tomography.
- Cellular immunity in patients with systemic juvenile rheumatoid arthritis.
- Rheumatic disease syndromes associated with antibodies to the Ro (SS-A) ribonuclear protein.
- Lupus nephritis: association between serology and renal biopsy measures.
- Immunological correlates of seasonal fluctuations in mood and behavior and their relationship to phototherapy.
- Rheumatic disease clinics of North America. AIDS and rheumatic disease. Introduction.
- The CR2 receptor (CD21) shows increased expression in the more differentiated cells of an antigen-specific B cell line.
- Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy.
- IgA related disorders in rheumatoid arthritis.
- Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis.
- IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome.
- Legionnaires'' disease in a patient with rheumatoid arthritis treated with cyclosporine.
- Inverse relationship between proliferation and differentiation in a human TNP-specific B cell line. Cell cycle dependence of antibody secretion.
- Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical features.
- Flow cytometry and the rheumatic diseases.
- Focal sialadenitis in patients with early synovitis.
- Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota.
- Rheumatoid arthritis in the Pima Indians: the intersection of epidemiologic, demographic, and genealogic data.
- Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
- Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia.
- What can we learn about rheumatic diseases by studying Pima Indians?
- Widespread pain and Sjögren's syndrome.
- Oral manifestations in patients with aplastic anemia.
- Protection from experimental endotoxemia by a recombinant adeno-associated virus encoding interleukin 10.
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.
- Salivary gland delivery of pDNA-cationic lipoplexes elicits systemic immune responses.
- Sex steroid hormones in primary Sjögren's syndrome.
- Differentiation of human bone marrow-derived cells into buccal epithelial cells in vivo: a molecular analytical study.
- Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.
- Clinical trials, outcome measures, and response criteria.
- Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
- Serum lipid levels in Sjögren's syndrome.
- Adult heart block is associated with disease activity in primary Sjögren's syndrome.
- B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjögren's syndrome.
- Outcome measures for Sjögren's syndrome, April 10-11, 2003, Bethesda, Maryland, USA.
- Lymphoma and other malignancies in primary Sjögren's syndrome.
- Distinct recognition of antibodies to centromere proteins in primary Sjogren''s syndrome compared with limited scleroderma.
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.
- Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease.
- Anti-CD3 monoclonal antibody treatment in newly diagnosed Type 1 diabetes patients: a hypothetical modelling analysis.
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Fellow (FACR)
Education
-
National Institutes of Health Clinical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Michael E. Crouch, MD |